Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Focus on safety

Swiss Medical Weekly

Volumn 137, Issue 47-48, 2007, Pages 657-659

  Veselka, Josef ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

CATHETER ABLATION; CLINICAL FEATURE; EDITORIAL; ENDOVASCULAR SURGERY; HEART ELECTROPHYSIOLOGY; HEART SURGERY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SAFETY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 36849061571     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Streit S, Walpoth N, Windecker S, Meier B, Hess O. Is alcohol ablation of the septum associated with recurrent tachyarrhytmias? Swiss Med Wkly. 2007;137(47-48):660-8.
2. Veselka J. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A review of the literature. Med Sci Monit. 2007;13:RA62-8.
3. Efthimiadis GK. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar. Eur Heart J. 2007;28:1270-1.
4. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet. 2000;355:425-6.
5. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-4.
6. Veselka J, Duchoňová R, Procházková Š, Páleníčková J, Sorajja P, Tesař D. Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. Am J Cardiol. 2005;95:675-8.
7. Lawrenz T, Lieder F, Bartelsmeier M, Leuner Ch, Borchert B, Meyer zu Vilsendorf D, et al. Predictors of complete heart block after transcoronary ablation of septal hypertrophy. J Am Coll Cardiol. 2007;49:2356-63.
8. Veselka J, Duchoňová R, Páleníč ková J, Zemánek D, Tišerová M, Linhartová K, et al. Impact of ethanol dosing on long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A single-center, prospective, and randomized study. Circ J. 2006;70:1550-2.
9. Faber L, Seggewiss H, Welge D, Fassbender D, Schmidt HK, Gleichmann U, et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr. 2004;5:347-55.
10. Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer zu Vilsendorf, et al. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2005;28:295-300.